Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $43 | $45 | $41 | $39 |
| % Growth | -3% | 9.8% | 5.4% | – |
| Cost of Goods Sold | $24 | $25 | $22 | $20 |
| Gross Profit | $19 | $19 | $18 | $18 |
| % Margin | 44.1% | 43.5% | 45.2% | 47.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4 | $4 | $2 | $1 |
| SG&A Expenses | $11 | $10 | $5 | $4 |
| Sales & Mktg Exp. | $7 | $6 | $3 | $3 |
| Other Operating Expenses | $7 | $2 | $0 | $0 |
| Operating Expenses | $18 | $12 | $9 | $9 |
| Operating Income | $1 | $7 | $8 | $9 |
| % Margin | 3.3% | 15.7% | 19.2% | 22.5% |
| Other Income/Exp. Net | -$2 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$0 | $6 | $7 | $8 |
| Tax Expense | $1 | $1 | $1 | $2 |
| Net Income | -$1 | $4 | $5 | $6 |
| % Margin | -2.5% | 9.9% | 12.8% | 16.8% |
| EPS | -2.44 | 9.91 | 11.77 | 14.32 |
| % Growth | -124.6% | -15.8% | -17.8% | – |
| EPS Diluted | -2.44 | 9.91 | 11.77 | 14.32 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $0 |
| Interest Expense | $2 | $2 | $1 | $1 |
| Depreciation & Amortization | $1 | $2 | $2 | $2 |
| EBITDA | $2 | $10 | $10 | $11 |
| % Margin | 5% | 22.2% | 23.7% | 27.5% |